Atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion: Review of ancillary testing modalities and implications for follow-up

Journal of Lower Genital Tract Disease

Volumn 14, Issue 3, 2010, Pages 206-214

  Davey, Diane Davis ^a   Greenspan, David L ^b   Kurtycz, Daniel F I ^c   Husain, Mujtaba ^d   Austin, R Marshall ^e  

^a UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c WISCONSIN STATE LABORATORY OF HYGIENE   (United States)

^d WAYNE STATE UNIVERSITY   (United States)

^e UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

ASC H; atypical squamous cells; cannot exclude high grade squamous intraepithelial lesion; cervical cytology; human papillomavirus; Pap test

Indexed keywords

PROTEIN P16;

ARTICLE; ATYPICAL SQUAMOUS CELL CANNOT EXCLUDE HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION; BIOPSY; COLPOSCOPY; DNA SCREENING; FOLLOW UP; GROUPS BY AGE; HISTOLOGY; HPV TEST; HUMAN; LABORATORY TEST; SENSITIVITY ANALYSIS; SQUAMOUS CELL; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; WART VIRUS; ADOLESCENT; ADULT; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; CHILD; CYTOCHEMISTRY; CYTOLOGY; EARLY DIAGNOSIS; FEMALE; ISOLATION AND PURIFICATION; MIDDLE AGED; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTIONS; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; UTERINE CERVIX; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; CHILD; EARLY DETECTION OF CANCER; FEMALE; HISTOCYTOCHEMISTRY; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREDICTIVE VALUE OF TESTS; YOUNG ADULT;

EID: 77954946965     PISSN: 10892591     EISSN: None     Source Type: Journal    
DOI: 10.1097/LGT.0b013e3181ca66a6     Document Type: Article

References (35)

1. Solomon D, Davey D, Kurman R, Moriarty A, OConnor D, Prey M, et al. The 2001 Bethesda System: Terminology for reporting results of cervical cytology. JAMA 2002;287:2114-9.
2. Wright TC, Massad S, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D, for the 2006 American Society for Colposcopy and Cervical Pathology-sponsored Consensus Conference. Consensus guidelines for the management of women with abnormal cervical screening tests. J Low Genit Tract Dis 2007;11:201-22.
3. Bandyopadhyay S, Austin RM, Dabbs D, Zhao C. Adjunctive human papillomavirus DNA testing is a useful option in some clinical settings for disease risk assessment and triage of females with ASC-H Papanicolaou test results. Arch Pathol Lab Med 2008;132:1874-81.
4. Davey DD, Neal MH,Wilbur DC, Colgan TJ, Styer PE, Mody DR. Bethesda 2001 implementation and reporting rates: 2003 practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology. Arch Pathol Lab Med 2004;128:1224-9.
5. Chivukula M, Shidham VB. ASC-H in Pap testV Definitive categorization of cytomorphological spectrum. Cytojournal 2006;3:14.
6. Patton AL, Duncan L, Bloom L, Phaneuf G, Zafar N. Atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion and its clinical significance in postmenopausal, pregnant, postpartum, and contraceptive-use patients. Cancer (Cancer Cytopathol) 2008;114:481-8.
7. Saad RS, Dabbs DJ, Kordunsky L, Kanbour-Shakir A, Silverman JF, Liu Y, et al. Clinical significance of atypical squamous cells, cannot exclude high grade, in perimenopausal and postmenopausal women. Am J Clin Pathol 2006;126: 381-8.
8. Sherman ME, Abdul-Karim FW, Berek JS, Powers CN, Sidawy MK, Tabbara SO. Atypical squamous cells. In: Solomon D, Nayar R, eds. The Bethesda System for Reporting Cervical Cytology. New York, NY: Springer-Verlag; 2004: 67-87.
9. Barreth D, Schepansky A, Capstick V, Johnson G, Steed H, Faught W. Atypical squamous cells-cannot exclude high-grade squamous intraepithelial lesion (ASC-H): A result not to be ignored. J Obstet Gynaecol Can 2006;28:1095-8.
10. Selvaggi SM. Reporting of atypical squamous cells, cannot exclude a high-grade squamous intraepithelial lesion (ASC-H) on cervical samples: Is it significant? Diagn Cytopathol 2003;29:38-41.
11. Sherman ME, Castle PE, Solomon D, for the ASCUS LSIL Triage Group. Cervical cytology of atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion (ASC-H): Characteristics and histologic outcomes. Cancer (Cancer Cytopathol) 2006;108:298-305.
12. Moriarty AT, Schwartz MR, Eversole G, Means M, Clayton A, Souers R, et al. Human papillomavirus testing and reporting rates: Practices of participants in the College of American Pathologists Interlaboratory Comparison Programin Gynecologic Cytology in 2006. Arch Pathol Lab Med 2008;132:1290-4.
13. McHale MT, Souther J, Elkas JC, Monk BJ, Harrison TA. Is atypical squamous cells, cannot exclude highgrade squamous intraepithelial lesion clinically significant? J Low Genit Tract Dis 2007;111:86-89.
14. Howell LP, Surasinghe S, Tabnak F. Impact of ASC-H terminology on the detection of HSILs in medically underserved California women. Diagn Cytopathol 2009;37:103-10.
15. Mokhtar GA, Delatour NL, Assiri AH, Gilliatt MA, Senterman M, Islam S. Atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion: Cytohistologic correlation study with diagnostic pitfalls. Acta Cytol 2008;52:169-77.
16. Louro AP, Roberson J, Eltoum I, Chhieng DC. Atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion: A follow-up study of conventional and liquid-based preparations in a high-risk population. Am J Clin Pathol 2003;120:392-7.
17. Evans MF, Adamson CSC, Papillo JL, St John TL, Leiman G, Cooper K. Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes. Cancer 2006;106:1054-64.
18. Liman AK, Giampoli EJ, Bonfiglio TA. Should women with atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion, receive reflex human papillomavirus testing? Cancer (Cancer Cytopathol) 2005;105:457-60.
19. Owens CL, Moats DR, Burroughs FH, Gustafson KS. BLow-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion[ is a distinct cytologic category: Histologic outcomes and HPV prevalence. Am J Clin Pathol 2007;128:398-403.
20. Rao A, Pather S, Dalrymple C, Mackie A, Deans R, Carter J. The role of HPV testing in patients with possible high-grade cervical cytology. J Obstet Gynaecol Res 2009;35: 503-6.
21. Reid-Nicholson M, Gatscha RM, Riedel ER, Lin O. Atypical squamous cells, cannot exclude high grade squamous intraepithelial lesion (ASC-H): Does HPV matter? Diagn Cytopathol 2007;35:1-5.
22. Siddiqui MT, Cohen C, Nassar A. Detecting high-grade cervical disease on ASC-H cytology: Role of BD ProEx C and Digene Hybrid Capture II HPV DNA testing. Am J Clin Pathol 2008;130:765-70.
23. Srodon M, Parry Dilworth H, Ronnett BM. Atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion: Diagnostic performance, human papillomavirus testing, and follow-up results. Cancer (Cancer Cytopathol) 2006;108:32-8.
24. Wu HH, Allen SL, Kirkpatrick JL, Elsheikh TM. Reflex high-risk human papilloma virus DNA test is useful in the triage of women with atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion. Diagn Cytopathol 2006;34:707-10.
25. You K, Liang X, Qin F, Guo Y, Geng L. High-risk human papillomavirus DNA testing and high-grade cervical intraepithelial lesions. Aust N Z J Obstet Gynaecol 2007;47:141-4.
26. Tsoumpou I, Arbyn M, Kyrgiou M, Wentzensen N, Koliopoulos G, Martin-Hirsch P, et al. P16INK4a immunostaining in cytological and histological specimens from the uterine cervix: A systematic review and meta-analysis. Cancer Treat Rev 2009;35:210-20.
27. Liu H, Shi J, Wilkerson M, Huang Y, Meschter S, Dupree W, et al. Immunohistochemical detection of p16INK4a in liquid-based cytology specimens on cell block sections. Cancer (Cancer Cytopathol) 2007;111:74-82.
28. Negri G, Moretto G, Menia E, Vittadello F, Kasal A, Mian C, et al. Immunocytochemistry of p16INK4a in liquidbased cervicovaginal specimens with modified Papanicolaou counterstaining. J Clin Pathol 2006;59:827-30.
29. Kotov P, Parameswaran L, Parisi JA, Chivukula M, Cafaro A, Fuentes M, et al. Application of p16INK4a immunostaining for definitive interpretation of ASC-H in liquid based cervical cytology smears with SurePath [abstract]. Mod Pathol 2005;18:69A.
30. Sung CO, Kim SR, Oh YL, Song SY. The use of p16INK4a immunocytochemistry in Batypical squamous cells which cannot exclude HSIL compared with Batypical squamous cells of undetermined significance in liquid-based cervical smears. Diagn Cytopathol 2009. E-pub ahead of print.
31. Benevolo M, Vocaturo A, Mottolese M, Mariani L, Vocaturo G, Marandino F, et al. Clinical role of p16INK4a expression in liquid-based cervical cytology: Correlation with HPV testing and histological diagnosis. Am J Clin Pathol 2008;129:606-12.
32. Duncan L, Jacob S, Hubbard E. Evaluation of p16INK4a as a diagnostic tool in the triage of Pap smears demonstrating atypical squamous cells of undetermined significance. Cancer (Cancer Cytopathol) 2008;114:34-48.
33. Lorenzato M, Caudroy S, Nou JM, Dalstein V, Joseph K, Bellefqih S, et al. Contribution of DNA ploidy image cytometry to the management of ASC cervical lesions. Cancer (Cancer Cytopathol) 2008;114:263-9.
34. Bonvicino A, Huitron S, Fadare O. Papanicolaou test interpretations of Batypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion: An investigation of requisite duration and number of colposcopic procedures to a definitive diagnosis of high-grade dysplasia in routine practice. Cancer (Cancer Cytopathol) 2007;111: 477-81.
35. Zhao C, Florea A, Austin RM. Clinical utility of adjunctive high-risk human papillomavirus DNA testing in women with Papanicolaou test findings of atypical glandular cells. Arch Pathol Lab Med 2010. In press.